BRVE
Ticker
Braveheart Bio, Inc.
BRVE · Healthcare · Braveheart Bio, Inc. a clinical-stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopat…Braveheart Bio, Inc. (BRVE), in the Healthcare sector, has 8 disclosed filings on Paydirt over the trailing twelve months from 8 corporate insiders: 8 purchases and 0 sales. Filers took a median of 0 days from execution to disclosure, and the most recent trade was executed Aug 7 and filed Aug 11. The most active filer was AH Bio Fund IV, L.P. with 1 filing.
Add to watchlistFilings, ttm
8
8 buys · 0 sells
Traders, ttm
8
8 insiders
Volume, ttmiDollar value disclosed in the window
$158.9M
estimated for Congress, as filed for insiders
Median delay
0d
execution to disclosure
Last traded
Aug 7
Filed Aug 11
ADViAverage daily dollar volume
–
not on file
Share price · 12M
$27.50 (-7.7%)
Adjusted for splits and dividends.
Volume by month
Buys $158.9M
Sells $0
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed
AP
AH Bio Fund IV, L.P.
10% owner
1 filing
ECRecent filings
AH Bio Fund IV, L.P.PURCHASE
10% owner
$19.8M1,100,000 sh × $18.00
Exec Aug 7
Filed Aug 11 · 5:53 PM ET Erez ChimovitsPURCHASE Director $34.9M
1,940,000 sh across 2 lots
Exec Aug 7
Filed Aug 11 · 5:31 PM ET Orbimed Advisors LlcPURCHASE Director $34.9M
1,940,000 sh across 2 lots
Exec Aug 7
Filed Aug 11 · 5:27 PM ET Forbion Growth Opportunities Fund III Cooperatief U.A.PURCHASE 10% owner $64.8M
3,600,000 sh across 2 lots
Exec Aug 7
Filed Aug 7 · 5:25 PM ET James Paul RickeyPURCHASE Chief Financial Officer $500K
27,777 sh × $18.00
Exec Aug 7
Filed Aug 7 · 4:41 PM ET Christopher ViehbacherPURCHASE Director $1.5M
83,333 sh × $18.00
Exec Aug 7
Filed Aug 7 · 4:31 PM ET Travis MurdochPURCHASE CEO and President $1.5M
83,333 sh × $18.00
Exec Aug 7
Filed Aug 7 · 4:30 PM ET David Charles LubnerPURCHASE Director $1000K
55,555 sh × $18.00
Exec Aug 7
Filed Aug 7 · 4:30 PM ET